Prof. Daniel Ketelhuth's academic career began at the University of Sao Paulo in Brazil, where he obtained a Biochemical-Pharmacy degree and later a doctoral degree in Immunology. Following that, he spent fourteen years at the Karolinska Institute, rising from postdoc to independent research leader. Prof. Ketelhuth joined the University of Southern Denmark in 2019, where he now leads a research team and spearheads the Centre for Advanced Cell Analysis, which is funded by the Novo Nordisk Foundation. Throughout his career, he has managed numerous projects and written several high-impact articles, making significant contributions to the field of immunometabolism in cardiovascular disease.
Main research questions
- Identify and characterize metabolic targets, e.g., enzymes and metabolites, involved in the modulation of vascular inflammation and the development of atherosclerosis and abdominal aortic aneurysms.
- Understand how the dynamics of metabolic dysregulation influence cardiometabolic disease.
- Decipher the complex immunometabolic communications underlying the mechanisms of plaque instability.
Group members
Silke Griepke Dam Nielsen - PhD candidate
Gustavo Luis Tripodi - Postdoc
Andrietta Grentzmann - PhD candidate
Odysseia Savvoulidou - PhD candidate
Jakob Hansen - PhD candidate
Michelle Due Nilsson - Research Assistant
Gitte Kitlen - Lab technician
Kristoffer Rosenstand - Lab technician
Ann Sofie Elkjær Madsen - Lab technician
Inger Nissen - Lab technician
Main funding
Novo Nordisk Foundation, European Commission, Danish Cardiovascular Academy/Danish Heart Association, Independent Fund Denmark, Simon Fougner Hartmanns Familiefond, SDU-Institute of Molecular Medicine.
Social media
ORCID: https://orcid.org/0000-0002-0087-116X
LinkedIn: https://www.linkedin.com/in/danielketelhuth/
@DKetelhuth: https://twitter.com/DKetelhuth
